Literature DB >> 6740085

Control of paralytic poliomyelitis in the United States.

L B Schonberger, J Kaplan, R Kim-Farley, M Moore, D L Eddins, M Hatch.   

Abstract

The changing annual vaccination status of the population and the greater than 1,000-fold drop in reported annual incidence of paralytic poliomyelitis between the early 1950s and early 1970s indicate that the control of poliomyelitis in the United States must be attributed to the use of both the inactivated poliovirus vaccine and oral poliovirus vaccine. The containment, in 1972 and 1979, of rare epidemics in poorly vaccinated subpopulations and the existence of only three reported cases of paralytic poliomyelitis clearly attributable to wild poliovirus in the last three years document a major triumph for public health. The continuing occurrence of vaccine-associated paralysis (six or seven reported cases per year, 1980-1982) indicates the necessity, despite the accomplishments, for continued review of the current vaccination strategy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6740085     DOI: 10.1093/clinids/6.supplement_2.s424

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  3 in total

1.  Molecular detection of an importation of type 3 wild poliovirus into Canada from The Netherlands in 1993.

Authors:  M A Drebot; M N Mulders; J J Campbell; O M Kew; K Fonseca; D Strong; S H Lee
Journal:  Appl Environ Microbiol       Date:  1997-02       Impact factor: 4.792

2.  The Spatial Dynamics of Poliomyelitis in the United States: From Epidemic Emergence to Vaccine-Induced Retreat, 1910-1971.

Authors:  Barry Trevelyan; Matthew Smallman-Raynor; Andrew D Cliff
Journal:  Ann Assoc Am Geogr       Date:  2005-06

Review 3.  Vaccine technologies: From whole organisms to rationally designed protein assemblies.

Authors:  Christopher P Karch; Peter Burkhard
Journal:  Biochem Pharmacol       Date:  2016-05-06       Impact factor: 5.858

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.